Hvsen Biotechnology (300871.SZ) Earnings Analysis
Hvsen Biotechnology (300871.SZ) has no confirmed upcoming earnings date. Trailing P/E 14.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300871.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300871.SZ. This page updates as the calendar is published.
300871.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 0.39 CNY | n/a | n/a | n/a |
| 2026-04-17 | 0.32 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.2496 CNY | n/a | n/a | n/a |
300871.SZ valuation and analyst view
| Trailing P/E | 14.75 |
|---|---|
| Trailing EPS | 1.424 CNY |
| Price / book | 1.91 |
| Dividend yield | 1.40% |
| Market cap | 4.10B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hvsen Biotechnology (300871.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300871.SZ. This page updates as the calendar is published.
Did 300871.SZ beat earnings last quarter?
Consensus estimate data was not available for 300871.SZ's 2026-04-27 report.
What is 300871.SZ's current P/E ratio and EPS?
300871.SZ trades at a trailing P/E of 14.75 on trailing EPS of 1.424328094232864 CNY.
What do analysts rate 300871.SZ?
300871.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.